Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3708739017 | Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3708740015 | Bendroflumethiazide- and nadolol-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4646571000052114 | läkemedel som innehåller bendroflumetiazid och nadolol, oral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Is a | Product containing bendroflumethiazide and nadolol (medicinal product) | true | Inferred relationship | Some | ||
| Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Has active ingredient | Nadolol (substance) | true | Inferred relationship | Some | 1 | |
| Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Has active ingredient | Bendroflumethiazide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Is a | Bendroflumethiazide-containing product in oral dose form | true | Inferred relationship | Some | ||
| Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Is a | Nadolol-containing product in oral dose form | true | Inferred relationship | Some | ||
| Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet | Is a | False | Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Inferred relationship | Some | |
| Bendroflumethiazide and nadolol only product in oral dose form | Is a | True | Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR